Pacific Biosciences of California Inc PACB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
PacBio Announces Third Quarter 2026 Financial Results
PacBio to Participate in Upcoming Investor Conferences
PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI
PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference
Trading Information
- Previous Close Price
- $1.97
- Day Range
- $1.84–2.00
- 52-Week Range
- $1.07–3.44
- Bid/Ask
- $1.86 / $1.93
- Shares Outstanding
- 312.24M
- Market Cap
- $611.98M
- Volume/Avg
- 7M / 12M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.73
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 485
- Website
- https://www.pacb.com
Valuation
Metric | PACB |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 3.73 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | PACB |
|---|---|
Quick Ratio | 3.57 |
Current Ratio | 4.62 |
Interest Coverage | −16.07 |
Quick Ratio
PACB
Profitability
Metric | PACB |
|---|---|
Return on Assets (Normalized) | −19.30% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −20.57% |
Return on Assets
PACB
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|F?nBnr> | LOCK|WB##q | $188B | |||
| Medtronic PLC MDT | LOCK|wXWkXGk | LOCK|f#<ms | $132B | |||
| Stryker Corp SYK | LOCK|%^lHl$$ | LOCK|%l? | $118B | |||
| Boston Scientific Corp BSX | LOCK|b>v&w! | LOCK|g>V! | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|bxN>fL> | LOCK|B&Mj% | $62B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|?$@>mXC | LOCK|tF | $38B | |||
| DexCom Inc DXCM | LOCK|Kq%@mwm | LOCK|>GXC | $31B | |||
| Koninklijke Philips NV ADR PHG | LOCK|?Rl | LOCK|^<x | $30B | |||
| Steris PLC STE | LOCK|ZbtYG!# | LOCK|Q@bL | $26B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|S&>gDRX | LOCK|Jv | $20B |
United States